ENDOLOGIX INC's ticker is and the CUSIP is 29266SAB2. A total of 14 filers reported holding ENDOLOGIX INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $3,495,000 | +19.9% | 4,000,000 | +81.8% | 0.00% | 0.0% |
| Q3 2016 | $2,914,000 | +60.0% | 2,200,000 | +57.1% | 0.00% | +100.0% |
| Q2 2016 | $1,821,000 | -58.4% | 1,400,000 | -69.6% | 0.00% | -66.7% |
| Q1 2016 | $4,382,000 | -26.5% | 4,600,000 | -16.4% | 0.00% | -25.0% |
| Q4 2015 | $5,964,000 | – | 5,500,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Context Capital Management, LLC | 3,500,000 | $3,793,000 | 5.91% |
| FNY Managed Accounts LLC | 500,000 | $542,190,000 | 2.68% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 30,000,000 | $32,548,000 | 1.32% |
| ZAZOVE ASSOCIATES LLC | 13,906,000 | $15,123,000 | 0.71% |
| DAFNA Capital Management LLC | 500,000 | $545,000 | 0.49% |
| SSI INVESTMENT MANAGEMENT LLC | 4,000,000 | $4,308,000 | 0.44% |
| CAMDEN ASSET MANAGEMENT L P /CA | 9,100,000 | $9,868,000 | 0.31% |
| LINDEN ADVISORS LP | 4,500,000 | $4,896,000 | 0.30% |
| WOLVERINE ASSET MANAGEMENT LLC | 11,000,000 | $11,949,000 | 0.26% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 300,000 | $327,000 | 0.05% |